Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
About this PQI
The purpose of this PQI is to understand the management techniques and interventions related to the utilization of the combination treatment of enfortumab vedotin-ejfv and pembrolizumab.
More About This PQI
PQI:
PQI in Action Articles:
PQI in Action Articles:
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/25/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Author: Tracelyn Freeman, PharmD, BCOP
Last Updated: 09/25/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/25/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 09/25/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management
Author: Atlanticare Cancer Care Institute | Cancer Specialists of North Florida
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/25/2025
PQI in Action: Fruquintinib (Fruzaqla®)
Author: Florida Cancer Specialists & Research Institute | Atlanticare Cancer Care Institute
Last Updated: 09/25/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 09/25/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E5: Global Health, Cancer Survivorship, and Advancing Equity
Author: Ginger Blackmon, PharmD | Ornesha Watson, PharmD, MS
Last Updated: 09/25/2025
S9 E4: Advancing Pharmacogenomics in Oncology
Author: Ginger Blackmon, PharmD | Sony Tuteja
Last Updated: 09/25/2025
S9 E3: Firefighter Health & Cancer Prevention
Author: Ginger Blackmon, PharmD | Tim Thompson
Last Updated: 09/25/2025
S9 E2: Love Languages in Cancer Care
Author: Ginger Blackmon, PharmD | Jenny Hoang, PharmD
Last Updated: 09/25/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 09/25/2025
Treatment Support Kit: Mirdametinib
Last Updated: 09/25/2025
Treatment Support Kit: Abemaciclib
Last Updated: 09/25/2025
Treatment Support Kit: Temozolomide
Last Updated: 09/25/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 09/25/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 09/25/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 09/25/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 09/25/2025
PQI in Action
PQI Podcast
PQI
PQI in Action
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/25/2025
PQI Podcast S6 Ep 7: Urology Clinic Best Practices
Author: Ginger Blackmon, PharmD | Melanie Boren MHA, RN, BSN, OCN | Robin Carr
Last Updated: 09/25/2025
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 09/25/2025
PQI in Action
PQI
PQI in Action
PQI in Action
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/25/2025
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 09/25/2025
PQI Podcast
PQI
The PQI Podcast S4 Ep 20: Cancer Immunotherapy
Author: Ginger Blackmon, PharmD | Mary Elizabeth Williams
Last Updated: 09/25/2025
PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma
Author: Jennifer Craig, PharmD, CSP | Amber Rollo, PharmD, CSP, AAHIVP
Last Updated: 09/25/2025
PQI
PQI in Action
PQI in Action
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 09/25/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 09/25/2025
PQI in Action
PQI Podcast
PQI
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/25/2025
The PQI Podcast S4 Ep 20: Cancer Immunotherapy
Author: Ginger Blackmon, PharmD | Mary Elizabeth Williams
Last Updated: 09/25/2025
PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma
Author: Jennifer Craig, PharmD, CSP | Amber Rollo, PharmD, CSP, AAHIVP
Last Updated: 09/25/2025
PQI Podcast
PQI
PQI Podcast
PQI Podcast
S9 E5: Global Health, Cancer Survivorship, and Advancing Equity
Author: Ginger Blackmon, PharmD | Ornesha Watson, PharmD, MS
Last Updated: 09/25/2025
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/25/2025
S9 E4: Advancing Pharmacogenomics in Oncology
Author: Ginger Blackmon, PharmD | Sony Tuteja
Last Updated: 09/25/2025
S9 E3: Firefighter Health & Cancer Prevention
Author: Ginger Blackmon, PharmD | Tim Thompson
Last Updated: 09/25/2025